Clinical Trials in Nashville

Showing 1881-1900 of 20,298 trials

OsteoGen Plug vs. Freeze-dried Bone Allograft With Collagen Barrier

NCT06447844

The study will be a multi-site, randomized, two-arm, controlled clinical trial using OsteoGen® Plug (Test) vs Freeze-dried Bone Allograft with collagen barrier (Control) for alveolar ridge preservation (ARP) in posterior extraction sites with intact buccal cortical plates.

Nonterminal Premolar Needing Extraction

McGuire Institute70 participantsStarted Mar 2024

Aurora, Colorado, United States • Broomfield, Colorado, United States • Boston, Massachusetts, United States +6 more locations

COMPLETEDPhase 3< 1 mile

Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

NCT03833167

This is a randomized, double-blind, study that compares pembrolizumab (MK-3475) with placebo given as adjuvant therapy in participants with high-risk locally advanced cutaneous squamous cell carcinoma (LA cSCC) that have undergone surgery with curative intent in combination with radiotherapy. The primary hypothesis is that pembrolizumab is superior to placebo in increasing recurrence free survival (RFS).

Carcinoma, Squamous Cell

Merck Sharp & Dohme LLC450 participantsStarted Apr 2019

Mobile, Alabama, United States • Duarte, California, United States • La Jolla, California, United States +178 more locations

OsteoGen Plug vs. Freeze-dried Bone Allograft With Collagen Barrier

Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

Find Trials by Condition in Nashville

Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)

Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Vafseo Outcomes In-Center Experience

Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

A Global Prospective Observational Registry of Patients With Pompe Disease

Acute MI Staging Diagnosis by High-sensitivity Cardiac Troponin-I

Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy

STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment